ࡱ> 685 CbjbjVV 4 <<C ////C/ >WWWWW222  #%B 22222 WW 2jWW 2 :,Wfm/" q  0 .&&&p2222222 222 2222&222222222 : MEDICAL BIOTECHNOLOGY WITH BIOBUSINESS (MRes (Consecutive)/MRes (Standard)/PgDip/PgCert) 91C5CSH9 (Consecutive)/91C5STH9 (Standard)/92C560VX/93C560VZ Qualifications: An Honours degree at 2:2 or above or equivalent qualification, in a relevant science subject. Duration: 16 24 months full time or 32 28 months part time (MRes); 9 months (PgDip); 4 months (PgCert) Aim: The programme will equip students with the skills and knowledge to take advantage of one of the fastest growing opportunities for employment. Medical Biotechnology requires scientists, business development professionals and people with excellent communication skills. Individuals with the imagination to exploit biotechnological thinking and the flair required to take scientific ideas through to new products or technologies will benefit greatly from, and enjoy, this programme. The course provides a unique opportunity to gain experience of the latest science and business developments in Medical Biotechnology, from tutors who are themselves actively engaged in this area and to experience a 9-month research project. Content; This course is designed for students requiring 120 ECTS credits (240 SCQF credits) at Masters level in preparation for admission to a PhD programme requiring 300 ECTS credits. The taught courses will comprise lectures, tutorials, practical classes and small group teaching and directed self-learning. The syllabus reflects recent developments in biotechnology that underpin medicine, including medical genetics, molecular immunology, the molecular basis of microbial pathogenesis and pharmacology. It is based in three science modules that develop both knowledge (laboratory methods in applied molecular biology, IT), and interpretation/communication skills. A fourth Bio-business module provides an introduction to market analysis, business governance, intellectual property, ethical issues in biotechnology, the generation of business plans and the making of commercially orientated presentations. The 9-month research project will either involve laboratory-based research in a biotechnological area or will entail the development of a complete business plan for a product or technology. Flexibility allows students to study 120 taught credits in Academic Year 1 (September to April) with the option to return in Academic Year 2 (September) or to continue in Academic Year 1 from April to undertake the research project subject to approval of the Programme Coordinator. Students will be advised on the appropriate route prior to admission. Candidates shall be required to attend the following designated programmes of course:- Stage 1 (September to January) Compulsory courses: BT 5009 Immunology Back to Basics (0 credit points) BT 5010 Small Molecular Drug Discovery (25 credit points) BT 5011 Introduction to Bio-business and Commercialisation of Bioscience (10 credit points) MT 5015 Molecular Biology Basics and Cloning Lab (15 credit points) MT 5016 Advanced Molecular & Functional Genomics (15 credit points) GS 50M1 Generic Skills (0 credit points) SK 5003 Information Skills (0 credit points) Stage 2 (February to April) Compulsory courses: BT 5503 Laboratory Training (10 credit points) BT 5508 Advanced Bio-Business (15 credit points) BT 5502 Special Study Module 2 Biologic Therapies (25 credit points) BT 5704 Extended Essay (10 credit points) Stage 3 (May or September to April) MB 50RP Research Project (120 credit points) Electives (extra credits): MT 55EP Careers & Employability for Postgraduates (0 credit points) Assessment: By practical work, by written essays and by oral presentations or by a combination of these as prescribed for each course. The thesis will be assessed and there may be an oral examination on completion of the programme. Candidates must pass all courses at an appropriate standard for the award of the MRes degree.   s w Q Z  `a>?@GIZ\]pqCDMjܺܬܟܒܬ{rgrgh9oh9oOJQJh9o>*OJQJhk[h9o>*OJQJh9o>*OJQJ^JhC!h9oOJQJ^Jhh9oOJQJ^Jh$fh9o6OJQJ^Jh$fh9o>*OJQJ^Jh9o6OJQJh9o6OJQJ^Jh9oOJQJ^JhC!h9o6OJQJ^Jh9oh9oOJQJ%Y  r s P Q   `aa Sgd9ogd9o  D%dgd9o?@\]qrCDjABCgd-gd[!gd9o Sgd9o Sgd9o@ABC» h-hCJh[!OJQJ^Jh h9oOJQJh9oOJQJh9o6OJQJh9o6>*OJQJh9oh9o6OJQJ21h:p[=. A!"#$% j 666666666vvvvvvvvv66666>66666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH nH sH tH N`N  Normal$a$ CJOJPJQJ_HmH sH tH `` + Heading 2$<@&$56CJOJPJQJ\]^JaJ>@>   Heading 3$d8@&5XX = Heading 6 <@&5CJOJPJQJ\^JaJRR "2^ Heading 7 <@&CJOJPJQJ^JaJXX N$ Heading 8 <@&6CJOJPJQJ]^JaJDA D Default Paragraph FontRiR 0 Table Normal4 l4a (k ( 0No List PP  Heading 3 Char5CJOJPJQJ^JaJ\\ +Heading 2 Char(56CJOJPJQJ\]^JaJtH 44 +Header  9r B!B + Header CharCJOJPJQJtH V1V =Heading 6 Char"5CJOJPJQJ\^JaJtH PAP "2^Heading 7 CharCJOJPJQJ^JaJtH JZRJ w0 Plain Text$a$CJOJQJ^JtH FaF w0Plain Text CharOJPJQJ^JVQrV ft Body Text 3$ 0d6a$ 5OJQJPP ftBody Text 3 Char5CJOJPJQJtH VV N$Heading 8 Char"6CJOJPJQJ]^JaJtH 6U6 mO Hyperlink >*B*phPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] C C C 8@0(  B S  ?(,;?KPQWGKX]jp48ES_E33ABEABEzp>}z<<^<`o(.^`o(()zLz^z`L.J J ^J `.  ^ `.L^`L.^`.^`.ZLZ^Z`L. ^`OJQJo(^`OJQJ^Jo(o pp^p`OJQJo( @ @ ^@ `OJQJo(^`OJQJ^Jo(o ^`OJQJo( ^`OJQJo(^`OJQJ^Jo(o PP^P`OJQJo(}zzp         VS BkwgH J&d =gu(,v[!)"Z%l.3g8[=Q@B|BCJqKLyLw}MmOk,QEuW^]"2^H_a;aMVataEc%'gQ=gy&jDzj\Al9o(tftvYxH y%z7g|4&}?7}sl=w ~(u.t9aj+M7R.~N$h-mO|5$mg;Sdz9B}%R9gCE@C@Unknown G*Ax Times New Roman5Symbol3. *Cx Arial7.{ @CalibriY CG TimesTimes New Roman7K@Cambria?= *Cx Courier New;WingdingsA BCambria Math"qhz=fz=fG G !20<<3HP $P 2!xxRobertRobert  Oh+'0 px  RobertNormalRobert2Microsoft Office Word@@|Ӡm@|ӠmG ՜.+,0 hp|  <  Title  !"#$&'()*+,./012347Root Entry Fm91Table&WordDocument4 SummaryInformation(%DocumentSummaryInformation8-CompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q